200 related articles for article (PubMed ID: 16615558)
1. [Cell therapy for Epstein-Barr virus-associated disease].
Kuzushima K
Nihon Rinsho; 2006 Mar; 64 Suppl 3():678-81. PubMed ID: 16615558
[No Abstract] [Full Text] [Related]
2. [Epstein-Barr virus].
Tsurumi T
Nihon Rinsho; 2003 Mar; 61 Suppl 3():582-6. PubMed ID: 12718032
[No Abstract] [Full Text] [Related]
3. Detection of clonal EBV episomes in lymphoproliferations as a diagnostic tool.
Langerak AW; Moreau E; van Gastel-Mol EJ; van der Burg M; van Dongen JJ
Leukemia; 2002 Aug; 16(8):1572-3. PubMed ID: 12145705
[No Abstract] [Full Text] [Related]
4. Epstein-Barr virus-associated lymphoproliferative disorders.
Rezk SA; Weiss LM
Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
[TBL] [Abstract][Full Text] [Related]
5. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-associated lymphomas.
Gandhi MK
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):77-89. PubMed ID: 16441211
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease.
Burns DM; Crawford DH
Blood Rev; 2004 Sep; 18(3):193-209. PubMed ID: 15183903
[TBL] [Abstract][Full Text] [Related]
8. [Oncogenic mechanisms of Epstein-Barr virus].
Herrero JA
Enferm Infecc Microbiol Clin; 1996 Nov; 14(9):551-60. PubMed ID: 9035714
[No Abstract] [Full Text] [Related]
9. Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.
O'Reilly RJ; Small TN; Papadopoulos E; Lucas K; Lacerda J; Koulova L
Springer Semin Immunopathol; 1998; 20(3-4):455-91. PubMed ID: 9870257
[No Abstract] [Full Text] [Related]
10. Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice.
Guinness ME; Kenney JL; Reiss M; Lacy J
Cancer Res; 2000 Oct; 60(19):5354-8. PubMed ID: 11034070
[TBL] [Abstract][Full Text] [Related]
11. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.
Cohen JI
Semin Hematol; 2003 Apr; 40(2):116-23. PubMed ID: 12704588
[TBL] [Abstract][Full Text] [Related]
12. [Epstein-Barr Virus Genome Replication as a Molecular Target for Cancer Therapy].
Noguchi K
Yakugaku Zasshi; 2019; 139(1):63-67. PubMed ID: 30606931
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for Epstein-Barr virus-associated cancers in children.
Straathof KC; Bollard CM; Rooney CM; Heslop HE
Oncologist; 2003; 8(1):83-98. PubMed ID: 12604735
[TBL] [Abstract][Full Text] [Related]
14. The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas.
Cader FZ; Kearns P; Young L; Murray P; Vockerodt M
Cancer Treat Rev; 2010 Jun; 36(4):348-53. PubMed ID: 20193983
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist.
Ng SB; Khoury JD
Adv Anat Pathol; 2009 Jan; 16(1):40-55. PubMed ID: 19098466
[TBL] [Abstract][Full Text] [Related]
16. Immune-cell treatment of Epstein--Barr-virus-associated lymphoproliferative disorders.
Swinnen LJ
Best Pract Res Clin Haematol; 2006; 19(4):839-47. PubMed ID: 16997187
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for Epstein-Barr virus-associated malignancies.
Long HM; Parsonage G; Fox CP; Lee SP
Drug News Perspect; 2010 May; 23(4):221-8. PubMed ID: 20520851
[TBL] [Abstract][Full Text] [Related]
18. [Characteristics of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease].
Kawa K
Rinsho Ketsueki; 2008 Jun; 49(6):390-6. PubMed ID: 18646606
[No Abstract] [Full Text] [Related]
19. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease.
Berger C; Day P; Meier G; Zingg W; Bossart W; Nadal D
J Med Virol; 2001 Aug; 64(4):505-12. PubMed ID: 11468736
[TBL] [Abstract][Full Text] [Related]
20. [Epstein-Barr virus (EBV)-associated lymphomas and lymphoproliferative disorders].
Shimoyama Y; Nakamura S; Asano N; Oshiro A; Oyama T
Nihon Rinsho; 2006 Mar; 64 Suppl 3():635-8. PubMed ID: 16615550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
